Mutares Surpasses Growth Targets Ahead of Schedule

Mutares' strong transaction pipeline, including a major SABIC deal, drives momentum. The firm now expects to hit its 2028 profit target in 2026, two years ahead of schedule.

While recent headlines have focused on covenant discussions, the operational performance of Munich-based investment firm Mutares is now commanding attention with a compelling growth narrative.

Accelerated Transaction Pipeline Drives Momentum

Mutares has entered the second quarter of 2026 with significant momentum, following a first quarter that saw three signed acquisitions and six signed exit transactions. The company is preparing to close five acquisitions imminently. These include the gas solutions division of Wärtsilä, the flooring business of Hamberger Industriewerke, and SABIC's engineering thermoplastics (ETP) operations in the Americas and Europe. Collectively, these three transactions represent annualized revenue of approximately €2.5 billion.

The SABIC ETP deal warrants particular focus. This business generates annual revenue of around €2.0 billion, carries equity of nearly €2.0 billion, and has historically produced operating results exceeding €500 million. Mutares has identified substantial potential for value enhancement within this portfolio.

On the divestment side, four exit closings are anticipated this quarter, including the sales of Conexus, Kalzip, inTime, and Relobus. Strategically, the firm is concentrating on energy and defense infrastructure sectors, where limited supply and strong investor demand are creating attractive valuation multiples.

2028 Profit Goal Now Within Sight

The forecast for 2026 is ambitious. Management expects group sales to reach between €7.9 billion and €9.1 billion, with the holding company's net income projected at €165 million to €200 million. Notably, the upper limit of €200 million matches the profit target Mutares had originally set for 2028. This performance puts the company a full two years ahead of its own strategic plan.

Chief Investment Officer Johannes Laumann described the transaction pipeline as being "more advanced than it has rarely been before," signaling a pronounced acceleration in the growth trajectory.

Bond Covenant Matter in the Background

The covenant topic related to the corporate bonds remains an open item. Mutares attributes the issue to IFRS 16 leasing effects and weaker portfolio exits in the final quarter of 2025. In response, the company plans to reduce its outstanding bond volume from the current €385 million to a range of €250 million to €300 million. The ongoing bondholder vote is widely regarded by the market as a largely procedural formality.

If Mutares successfully executes its dense transaction pipeline this spring as planned, balance sheet pressures are expected to ease rapidly. This would allow the company's operational growth story to move decisively to the forefront.